Gainers
- Lucy Scientific Discovery (NASDAQ:LSDI) shares moved upwards by 205.8% to $1.56 during Thursday's regular session. The company's market cap stands at $2.7 million.
- SINTX Techs (NASDAQ:SINT) shares moved upwards by 31.66% to $0.17. The company's market cap stands at $20.6 million. As per the news, the Q1 earnings report came out 3 days ago.
- Nanoviricides (AMEX:NNVC) stock increased by 23.56% to $2.22. The market value of their outstanding shares is at $26.1 million. The company's, Q3 earnings came out yesterday.
- Scorpius Holdings (AMEX:SCPX) shares moved upwards by 23.35% to $0.1. The company's market cap stands at $3.4 million.
- Onconetix (NASDAQ:ONCO) stock moved upwards by 23.29% to $0.14. The market value of their outstanding shares is at $3.0 million.
- NRX Pharmaceuticals (NASDAQ:NRXP) stock increased by 19.98% to $3.88. The market value of their outstanding shares is at $40.9 million. As per the news, the Q1 earnings report came out 2 days ago.
Losers
- Eyenovia (NASDAQ:EYEN) stock decreased by 24.1% to $0.81 during Thursday's regular session. The market value of their outstanding shares is at $41.0 million. The company's, Q1 earnings came out yesterday.
- 180 Life Sciences (NASDAQ:ATNF) stock decreased by 22.17% to $1.51. The company's market cap stands at $1.3 million. As per the news, the Q1 earnings report came out yesterday.
- Omeros (NASDAQ:OMER) stock decreased by 20.99% to $3.29. The market value of their outstanding shares is at $190.9 million. The company's, Q1 earnings came out yesterday.
- Elicio Therapeutics (NASDAQ:ELTX) shares fell 17.31% to $8.6. The market value of their outstanding shares is at $87.9 million. As per the press release, Q1 earnings came out yesterday.
- Biotricity (NASDAQ:BTCY) stock decreased by 11.41% to $1.01. The company's market cap stands at $9.5 million.
- T2 Biosystems (NASDAQ:TTOO) stock decreased by 10.22% to $5.36. The market value of their outstanding shares is at $72.5 million.
This article was generated by Benzinga's automated content engine and reviewed by an editor.